Western Europe, n = 331 | Middle Europe, n = 210 | Southern Europe, n = 388 | Northern Europe, n = 100 | Total, n = 1029 | |
---|---|---|---|---|---|
Patient characteristics | |||||
Females | 70 (21) | 43 (21) | 88 (23) | 27 (27) | 228 (22) |
Age > 55 yrs | 221 (64) | 118 (56) | 166 (43) | 59 (59) | 554 (54) |
Higher education | 146 (44) | 46 (22) | 181 (47) | 25 (25) | 398 (39) |
Employed | 124 (38) | 105 (50) | 242 (62) | 41 (41) | 512 (50) |
Comorbidities, mean (0–5) | 1.5 (1.3) | 1.8 (1.4) | 2.0 (1.6) | 1.5 (1.2) | 1.8 (1.5) |
Knowledgeable about disease | 104 (31) | 58 (28) | 228 (59) | 20 (20) | 410 (40) |
Knowledgeable about lifestyle | 235 (71) | 187 (89) | 332 (86) | 75 (75) | 829 (81) |
Care characteristics | |||||
Treated with ULT | 179 (54) | 116 (55) | 262 (68) | 47 (47) | 604 (59) |
Regular follow-ups (≥ 2) | 141 (43) | 93 (44) | 172 (44) | 17 (17) | 423 (41) |
Diagnosed by GP | 258 (78) | 150 (71) | 262 (68) | 76 (76) | 746 (73) |
Country characteristicsa, mean (SD) | |||||
GDP (Int$, in thousands) | 53.4 (10.2) | 56.6 (4.9) | 41.3 (2.1) | 58.2 (5.5) | 49.9 (9.5) |
HCE (Int$, in thousands) | 5.0 (0.1) | 6.1 (0.5) | 3.4 (0.1) | 5.6 (0.3) | 4.7 (1.1) |
Gout health outcomes | |||||
≥ 3 gout flares in past year | 106 (32) | 61 (29) | 116 (30) | 41 (41) | 324 (32) |
≥ 1 gout flare in past year | 235 (71) | 128 (61) | 296 (76) | 65 (65) | 724 (70) |
Patient-experienced outcomes | |||||
Impact of gout on mental and physical health | 131 (40) | 60 (29) | 218 (56) | 34 (34) | 443 (43) |
Missed ≥ 1 day of workb | 58 (47) | 51 (49) | 140 (58) | 15 (37) | 264 (52) |
Satisfaction with current medication | 273 (83) | 165 (79) | 306 (79) | 74 (74) | 818 (80) |
Unaddressed treatment goals (0–9), mean (SD) | 1.1 (1.3) | 1.1 (1.3) | 1.2 (1.1) | 1.2 (1.4) | 1.1 (1.2) |
Values are expressed as n (%) unless otherwise indicated.
↵aInternational dollars (Int$) extracted from the Organisation for Economic Co-operation and Development (2018 or latest available; www.oecd.org).
↵bOnly employed patients (512/1029 [50%]). GDP: gross domestic product; GP: general practitioner; HCE: healthcare expenditures; ULT: urate-lowering therapy.